{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:32:45Z","timestamp":1772580765308,"version":"3.50.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T00:00:00Z","timestamp":1451347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0141960","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T18:56:13Z","timestamp":1451415373000},"page":"e0141960","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effects of RXR Agonists on Cell Proliferation\/Apoptosis and ACTH Secretion\/Pomc Expression"],"prefix":"10.1371","volume":"10","author":[{"given":"Akiko","family":"Saito-Hakoda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Uruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehana","family":"Parvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Saito-Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotaka","family":"Kogure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuma","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kagechika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumasa","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Kure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadayoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,12,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrendo.2011.12","article-title":"Management of Cushing disease","volume":"7","author":"NA Tritos","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1517\/13543784.17.5.669","article-title":"Pituitary-targeted medical therapy of Cushing's disease","volume":"17","author":"KI Alexandraki","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.addr.2010.07.003","article-title":"Retinoid pathway and cancer therapeutics","volume":"62","author":"N Bushue","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1172\/JCI11098","article-title":"Retinoic acid prevents experimental Cushing syndrome","volume":"108","author":"M Paez-Pereda","year":"2001","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1210\/en.2005-0958","article-title":"Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action","volume":"147","author":"D Giacomini","year":"2006","journal-title":"Endocrinology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1210\/en.2006-0414","article-title":"Retinoic acid as a novel medical therapy for Cushing's disease in dogs","volume":"147","author":"V Castillo","year":"2006","journal-title":"Endocrinology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11154-008-9080-6","article-title":"Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas","volume":"10","author":"M Labeur","year":"2009","journal-title":"Rev Endocr Metab Disord"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1210\/jc.2012-2328","article-title":"Potential role for retinoic acid in patients with Cushing's disease","volume":"97","author":"F Pecori Giraldi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1507\/endocrj.EJ14-0115","article-title":"Retinoic acid receptor-\u03b1 up-regulates proopiomelanocortin gene expression in AtT20 corticotroph cells","volume":"61","author":"A Uruno","year":"2014","journal-title":"Endocr J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.tem.2010.06.009","article-title":"Retinoid X receptors: common heterodimerization partners with distinct functions","volume":"21","author":"P Lefebvre","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1124\/pr.58.4.7","article-title":"International Union of Pharmacology. LXIII. Retinoid X receptors","volume":"58","author":"P Germain","year":"2006","journal-title":"Pharmacol Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1158\/0008-5472.CAN-08-4407","article-title":"Therapeutic potential of "rexinoids" in cancer prevention and treatment","volume":"69","author":"T Tanaka","year":"2009","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrc2129","article-title":"Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer","volume":"7","author":"KT Liby","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1158\/1078-0432.CCR-07-1065","article-title":"Rexinoids and breast cancer prevention","volume":"13","author":"LR Howe","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nrd2397","article-title":"RAR and RXR modulation in cancer and metabolic disease","volume":"6","author":"L Altucci","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00280-009-1140-4","article-title":"Bexarotene: a promising anticancer agent","volume":"65","author":"L Qu","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/bbrc.1997.6414","article-title":"Action mechanism of retinoid-synergistic dibenzodiazepines","volume":"233","author":"H Umemiya","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1021\/jm9704309","article-title":"Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers","volume":"40","author":"H Umemiya","year":"1997","journal-title":"J Med Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1021\/jm0255320","article-title":"Novel retinoid X receptor antagonists: specific inhibition of retinoid synergism in RXR-RAR heterodimer actions","volume":"45","author":"B Takahashi","year":"2002","journal-title":"J Med Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1021\/jm0581821","article-title":"Synthetic retinoids: recent developments concerning structure and clinical utility","volume":"48","author":"H Kagechika","year":"2005","journal-title":"J Med Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"9676","DOI":"10.1074\/jbc.M104560200","article-title":"Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-gamma via an interaction with Sp1 in vascular smooth muscle cells","volume":"277","author":"A Sugawara","year":"2002","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0092-8674(91)90020-Y","article-title":"Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors","volume":"65","author":"K Umesono","year":"1991","journal-title":"Cell"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"10910","DOI":"10.1074\/jbc.271.18.10910","article-title":"Vitamin D receptors repress basal transcription and exert dominant negative activity on triiodothyronine-mediated transcriptional activity","volume":"271","author":"PM Yen","year":"1996","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"14235","DOI":"10.1016\/S0021-9258(18)47928-8","article-title":"Provasopressin-neurophysin II processing is cell-specific in heterologous cell lines expressing a metallothionein-vasopressin fusion gene","volume":"262","author":"BJ Cwikel","year":"1987","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e39950","DOI":"10.1371\/journal.pone.0039950","article-title":"Orphan nuclear receptor Nur77 regulates androgen receptor gene expression in mouse ovary","volume":"7","author":"A Dai","year":"2012","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1677\/JME-08-0167","article-title":"Short term regulation of aldosterone secretion after stimulation and suppression experiments in mice","volume":"42","author":"A Spyroglou","year":"2009","journal-title":"J Mol Endocrinol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5494\/wjh.v4.i1.7","article-title":"ARB affects nicotine-induced gene expression profile in human coronary artery endothelial cells","volume":"4","author":"M Kudo","year":"2014","journal-title":"World J Hypertens"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1210\/endo.136.4.7895689","article-title":"Isoform-specific retinoid-X receptor (RXR) antibodies detect differential expression of RXR proteins in the pituitary gland","volume":"136","author":"A Sugawara","year":"1995","journal-title":"Endocrinology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.1128\/MCB.17.10.5946","article-title":"Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells","volume":"17","author":"A Philips","year":"1997","journal-title":"Mol Cell Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.1128\/MCB.19.11.7549","article-title":"Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation","volume":"19","author":"M Maira","year":"1999","journal-title":"Mol Cell Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1128\/MCB.13.4.2342","article-title":"Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene","volume":"13","author":"M Therrien","year":"1993","journal-title":"Mol Cell Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1128\/MCB.17.11.6673","article-title":"NeuroD1\/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene","volume":"17","author":"G Poulin","year":"1997","journal-title":"Mol Cell Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/358587a0","article-title":"Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid","volume":"358","author":"XK Zhang","year":"1992","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbalip.2011.04.003","article-title":"Modulation of RXR function through ligand design","volume":"1821","author":"E P\u00e9rez","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1200\/JCO.1997.15.2.790","article-title":"Initial clinical trial of a selective retinoid X receptor ligand, LGD1069","volume":"15","author":"VA Miller","year":"1997","journal-title":"J Clin Oncol"},{"key":"ref36","first-page":"581","article-title":"Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma","volume":"137","author":"M Duvic","year":"2001","journal-title":"Arch Dermatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1158\/1535-7163.MCT-08-0753","article-title":"UBE1L causes lung cancer growth suppression by targeting cyclin D1","volume":"7","author":"Q Feng","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"29987","DOI":"10.1074\/jbc.M701700200","article-title":"p21WAF1\/CIP1 is a common transcriptional target of retinoid receptors: pleiotropic regulatory mechanism through retinoic acid receptor (RAR)\/retinoid X receptor (RXR) heterodimer and RXR\/RXR homodimer","volume":"282","author":"T Tanaka","year":"2007","journal-title":"J Biol Chem"},{"key":"ref39","first-page":"1234","article-title":"Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action","volume":"8","author":"C Zhang","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/me.2007-0533","article-title":"Liver X receptor-alpha regulates proopiomelanocortin (POMC) gene transcription in the pituitary","volume":"23","author":"S Matsumoto","year":"2009","journal-title":"Mol Endocrinol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2011.02.048","article-title":"Liver X receptor-alpha\/beta expression ratio is increased in ACTH-secreting pituitary adenomas","volume":"494","author":"K Hashimoto","year":"2011","journal-title":"Neurosci Lett"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/nm784","article-title":"Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas","volume":"8","author":"AP Heaney","year":"2002","journal-title":"Nat Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/B:PITU.0000011176.05771.46","article-title":"Novel pituitary ligands: peroxisome proliferator activating receptor-gamma","volume":"6","author":"AP Heaney","year":"2003","journal-title":"Pituitary"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"R546","DOI":"10.1186\/bcr913","article-title":"A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands","volume":"6","author":"DL Crowe","year":"2004","journal-title":"Breast Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2008.03620.x","article-title":"Regulation of proopiomelanocortin gene expression: an overview of the signaling cascades, transcription factors, and responsive elements involved","volume":"1163","author":"BG Jenks","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.1925541","article-title":"Identification of the DNA binding site for NGFI-B by genetic selection in yeast","volume":"252","author":"TE Wilson","year":"1991","journal-title":"Science"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0092-8674(01)00282-3","article-title":"A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins","volume":"104","author":"B Lamolet","year":"2001","journal-title":"Cell"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1074\/jbc.M313063200","article-title":"NF-kappaB participates in the corticotropin-releasing, hormone-induced regulation of the pituitary proopiomelanocortin gene","volume":"278","author":"KP Karalis","year":"2004","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.bcp.2008.08.005","article-title":"The RXR agonists PA024 and HX630 have different abilities to activate LXR\/RXR and to induce ABCA1 expression in macrophage cell lines","volume":"76","author":"T Nishimaki-Mogami","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"ref50","first-page":"49","article-title":"Clinically potential subclasses of retinoid synergists revealed by gene expression profiling","volume":"2","author":"S Ishida","year":"2003","journal-title":"Mol Cancer Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0141960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T02:28:46Z","timestamp":1653964126000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0141960"}},"subtitle":[],"editor":[{"given":"Austin John","family":"Cooney","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,29]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0141960","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,29]]}}}